Paushak Ltd. (BSE: 532742) is a Vadodara, Gujarat-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹2,046 Cr, it ranks #1,227 by market cap among the 6,137 Indian listed companies on FinBizNet, and #6 of 13 in Custom Synthesis and Specialty CDMO. At ₹621.05 (as of 25 Oct 2026), the share price is 29.6% below its 52-week high of ₹881.95 and 81.3% above its 52-week low of ₹342.50.
| Current Price | ₹621.05 |
|---|---|
| Market Cap | ₹2,046 Cr |
| BSE Code | 532742 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| P/E Ratio | 42.9 |
| Return on Equity | 8.22% |
| Return on Assets | 4.01% |
| 52-Week Range | ₹342.50 – ₹881.95 |
| 3-Month Price Change | +10.4% |
| Beta (1Y) | 0.58 |
| Dividend Yield | 0.37% |
| Headquarters | Vadodara, Gujarat |
| Website | www.paushak.com |
| Revenue | ₹84 Cr |
|---|---|
| Net Profit | ₹15 Cr |
| Net Margin | 18.1% |
| EPS (Basic) | ₹6.13 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Paushak Limited manufactures and sells specialty chemicals and intermediates in India and internationally. It offers chloroformates, isocyanates, chlorides, carbonate/carbamate, and custom synthesis and CDMO. The company servers its products to pharmaceuticals, agrochemicals, and performance and custom synthesis industries. Paushak Limited was founded in 1968 and is based in Vadodara, India.
1. Speciality Chemicals-This segment develops, manufactures, and sells phosgene based specialty chemicals and intermediates.
1. Speciality Chemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,389 Cr | 73.6 | 5.76% | ₹655 Cr | -2.2% |
| Neogen Chemicals Limited (Neogen) | ₹7,465 Cr | 227.6 | 3.58% | ₹250 Cr | +45.2% |
| Laxmi Organic Industries Ltd | ₹4,963 Cr | 59.9 | 4.08% | ₹968 Cr | -27.6% |
| Tatva Chintan Pharma Chem Ltd | ₹4,547 Cr | 105.8 | 5.53% | ₹217 Cr | +22.0% |
| Prasol Chemicals Limited | ₹4,476 Cr | 50.7 | — | ₹434 Cr | — |
| Paushak Ltd. | ₹2,046 Cr | 42.9 | 8.22% | ₹84 Cr | — |
| Sunshield Chemicals Ltd. | ₹906 Cr | 27.7 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹803 Cr | 33.4 | 4.80% | ₹65 Cr | -27.6% |
| Arvee Laboratories (India) Ltd | ₹249 Cr | 93.9 | 7.78% | ₹17 Cr | +17.6% |
Listed by market capitalisation. Ratios are shown for context only.
Paushak Ltd. is trading at ₹621.05, with a market capitalisation of ₹2,046 Cr.
Paushak Ltd. operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Paushak Ltd. has a P/E of 42.9 and a return on equity of 8.22%.
Paushak Ltd. is listed on the BSE under the scrip code 532742.
In Q1 FY27, Paushak Ltd. reported revenue of ₹84 Cr and net profit of ₹15 Cr, with basic EPS of ₹6.13 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.